Modification of spatial recognition memory and object discrimination after chronic administration of haloperidol, amitriptyline, sodium valproate or olanzapine in normal and anhedonic rats

International Journal of Neuropsychopharmacology

Volumn 10, Issue 3, 2007, Pages 345-357

  Orsetti, Marco ^a   Colella, Luciana ^a   Dellarole, Anna ^a   Luigi Canonico, Pier ^a   Ghi, Piera ^b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Chronic mild stress; Olanzapine; Rat; Spatial memory; Visual memory

Indexed keywords

AMITRIPTYLINE; HALOPERIDOL; OLANZAPINE; SUCROSE; VALPROIC ACID;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; MALE; MENTAL TASK; NONHUMAN; OBJECT RELATION; PRIORITY JOURNAL; RAT; RECOGNITION; SPATIAL DISCRIMINATION; SPATIAL MEMORY; TASK PERFORMANCE; VISUAL MEMORY;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CHRONIC DISEASE; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD PREFERENCES; HALOPERIDOL; MALE; MAZE LEARNING; MEMORY; RATS; RATS, WISTAR; RECOGNITION (PSYCHOLOGY); SPACE PERCEPTION; STRESS, PSYCHOLOGICAL; TASTE; VALPROIC ACID;

EID: 34247895499     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145706006705     Document Type: Article

References (44)

1. Altman HJ, Normile HJ (1988). What is the nature of the role of the serotonergic nervous system in learning and memory? prospects for the development of an effective treatment strategy for senile dementia. Neurobiology of Aging 9, 627-638.
2. Amado-Boccara I, Gougoulis N, Poirier Littrè MF, Galinowski A, Loo H (1995). Effects of antidepressants on cognitive functions: a review. Neuroscience and Biobehavioral Review 19, 479-493.
3. Beck KD, Luine VN (1999). Food deprivation modulates chronic stress effects on object recognition in male rats: role of monoamines and amino acids. Brain Research 830, 56-71.
4. Bilder RM (1997). Neurocognitive impairment in schizophrenia and how it affects treatment options. Canadian Journal of Psychiatry 42, 255-264.
5. Conrad CD, Galea LAM, Kuroda Y, McEwen BS (1996). Chronic stress impairs rat spatial memory on the Y-maze and this effect is blocked by tianeptine pre-treatment. Behavioural Neuroscience 110, 1321-1334.
6. Cuesta MJ, Peralta V, Zarzuela A (2001). Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophrenia Research 48, 17-28.
7. Dellu F, Mayo W, Cherkaoui J, Le Moal M, Simon H (1992). A two-trial memory task with automated recording: study in young and aged rats. Brain Research 588, 132-139.
8. Ferretti C, Blengio M, Ricci Gamalero S, Ghi P (1995). Biochemical and behaviour changes induced by acute stress in a chronic variate stress model of depression: the effect of amitriptyline. European Journal of Pharmacology 280, 19-26.
9. Gallassi R, Morreale A, Lorusso S, Procaccianti G, Lugaresi E, Baruzzi A (1990). Cognitive effects of valproate. Epilepsy Research 5, 160-164.
10. Ghi P, Ferretti C, Blengio M (1995). Effects of different types of stress on histamine-H3 receptors in the rat cortex. Brain Research 28, 104-107.
11. Ghi P, Orsetti M, Ricci Gamalero S, Ferretti C (1999). Sex differences in memory performance in the object recognition test. Possible role of histamine receptors. Pharmacology, Biochemistry and Behaviour 64, 761-766.
12. Green M (1996). What are the consequences of the neurocognitive deficits in schizophrenia? American Journal of Psychiatry 154, 799-804.
13. Hoff AL, Shukla S, Aronson T, Cook B, Ollo CL, Baruch S, Jandorf L, Schwartz J (1990). Failure to differentiate bipolar disorder from schizophrenia on measures of neuropsychological function. Schizophrenia Research 3, 253-260.
14. Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY (2002). Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 26, 325-339.
15. Izquierdo I, Medina JH (1997). Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiology of Learning and Memory 68, 285-316.
16. Kapur S, Zipursky RB, Remington G, Jones C, DaSilva J, Wilson AA, Houle S (1998). 5HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. American Journal of Psychiatry 156, 286-293.
17. Katz R (1982). Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacology, Biochemistry and Behaviour 16, 965-968.
18. Keefe RSE, Silva SG, Perkins DO, Lieberman JA (1999). The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and metaanalysis. Schizophrenia Bulletin 25, 201-222.
19. King DJ (1990). The effect of neuroleptics on cognitive and psychomotor function. British Journal of Psychiatry 157, 799-811.
20. Lawlor BA, Sunderland T, Mellow AM, Hill JL, Molchan SE, Murphy DL (1989). Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. Archives of General Psychiatry 46, 542-549.
21. Luine V, Villegas M, Martinez C, McEwen BS (1994). Repeated stress causes reversible impairments of spatial memory performance. Brain Research 639, 167-170.
22. Meneses A, Hong E (1997). A pharmacological analysis of serotonergic receptors: effect of their activation or blockade in learning. Progress in Neuro-Psychopharmacology and Biological Psychiatry 21, 273-296.
23. Nabeshima TK, Itoh K, Kawashima K, Kameyama T (1989). Effects of 5HT2 receptor antagonist on cycloheximide-induced amnesia in mice. Pharmacology, Biochemistry and Behaviour 32, 787-790.
24. Ninan I, Kulkarni SK (1999). Effect of olanzapine on behavioural changes induced by FG 7142 and dizocilpine on active avoidance and plus maze tasks. Brain Research 830, 337-344.
25. Noda Y, Ochi Y, Shimada E, Oka M (1991). Involvement of central cholinergic mechanism in RU-24969-induced behavioral deficit. Pharmacology, Biochemistry and Behaviour 38, 441-446.
26. Orsetti M, Colella L, Dellarole A, Canonico PL, Ferri S, Ghi P (2005). Effects of chronic administration of olanzapine, amitriptyline, haloperidol or sodium valproate in naive and anhedonic rats. International Journal of Neuropsychopharmacology. doi:10.1017/S146114570500564X. Published online 21 June 2005.
27. 3-receptor antagonism improves memory retention and reverses the cognition deficit induced by scopolamine in a two-trial place recognition task. Behavioural Brain Research 124, 235-242.
28. Papp M, Moryl E, Willner P (1996). Pharmacological validation of the chronic mild stress model of depression. European Journal of Pharmacology 296, 129-136.
29. Park CR, Campbell AM, Diamond DM (2001). Chronic psychosocial stress impairs learning and memory and increases sensitivity to yohimbine in adult rats. Biological Psychiatry 50, 994-1004.
30. Pavone F, Battaglia M, Sansone M (1997). Prevention of amitriptyline-induced avoidance impairment by tacrine in mice. Behavioural Brain Research 89, 229-236.
31. Porter RJ, Gallagher P, Thompson JM, Young AH (2003). Neurocognitive impairment in drug-free patients with major depressive disorder. British Journal of Psychiatry 182, 214-220.
32. Rybakowski JK, Borkowska A (2001). The effect of treatment with risperidone, olanzapine or phenothiazines on cognitive functions in patients with schizophrenia. International Journal of Psychiatry and Clinical Practice 5, 249-256.
33. Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002). Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26, 583-594.
34. Silverstein ML, McDonald C, Meltzer HY (1988). Differential patterns of neuropsychological deficit in psychiatric disorders. Journal of Clinical Psychology 44, 412-415.
35. Silverstein ML, Strauss BS, Fogg L (1990). A cluster analysis approach for deriving neuropsychologically-based subtypes of psychiatric disorders. International Journal of Clinical Neuropsychology 12, 7-13.
36. Skarsfeldt T (1996). Differential effect of antipsychotics on the navigation in the Morris water maze - a comparative study between novel and reference antipsychotics. Psychopharmacology 124, 126-133.
37. Smith RC, Infante M, Singh A, Khandat A (2001). The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia. International Journal of Neuropsychopharmacology 4, 239-250.
38. Stein RA, Strickland TL (1998). A review of the neuropsychological effects of commonly used prescription medications. Archives of Clinical Neuropsychology 13, 259-284.
39. Stoll AL, Locke CA, Vuckovic A, Mayer PV (1996). Lithium-associated cognitive and functional deficits reduced by a switch to divalproex sodium: a case series. Journal of Clinical Psychiatry 57, 356-359.
40. Trichard C, Martinot JL, Alagille M, Masure MC, Hardy P, Ginestet D, Feline A (1995). Time course of prefrontal lobe dysfunction in severely depressed in-patients: a longitudinal neuropsychological study. Psychological Medicine 25, 79-85.
41. Van Gorp WG, Altshuler LL, Wilkins J, Dixon W (1998). Cognitive impairment in euthymic bipolar patients with and without prior alcohol abuse: a preliminary study. Archives of General Psychiatry 55, 41-46.
42. Vasconcellos APS, Tabajara AS, Ferrari C, Rocha E, Dalmaz C (2003). Effect of chronic stress on spatial memory in rats is attenuated by lithium treatment. Physiology and Behavior 79, 143-149.
43. Verdoux H, Magnin E, Bourgeois M (1995). Neuroleptic effect on neuropsychological test performance in schizophrenia. Schizophrenia Research 14, 133-139.
44. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987). Reduction of sucrose preference by chronic mild stress and its restoration by a tricyclic antidepressant. Psychopharmacology 93, 358-364.